- Danish stocks
- Norwegian stocks
- Swedish stocks
- AktieTorget
- A1M Pharma
- Accelerator Nordic
- AlphaHelix
- AroCell
- Biotech-IgG
- Brighter
- Clinical Laserthermia
- Emotra
- Enzymtica
- Eurocine Vaccines
- European Inst. of Science
- IDL Biotech
- Medfield Diagnostics
- MedicPen
- MediRox
- MediRätt
- Micropos Medical
- PharmaLundensis
- Respiratorius
- Rubicon Life Science
- SensoDetect
- WntResearch
- Orasolv
- Senzime
- SPAGO Imaging
- Vivoline Medical
- First North Stockholm
- OMX Stockholm A-F
- OMX Stockholm G-Z
- AktieTorget
- US stocks
- General discussion
- All posts
Bioporto VS Phadia. Dommen fra Sø&Handelsretten.
Udskrift fra Sø&Handelsrettens Dombog.
DOM Afsagt den 15. juni 2012 T-9-07 BioPorto Diagnostics A/S (Advokat Morten Bruus) mod Phadia A/S (Advokat Peter-Ulrik Plesner)
About Karl M. Bidstrup
Tidligere ejer af Medicoinvestor.com Strategien har gennem mange år været at profitere på etablerede aktier, og brænde det hele af på Bioporto... Sad but true. Kontakt mig på medicoinvestor(A)gmail.com hvis du har en million du ikke ved hvor du skal gemme, så skal jeg nok holde den for dig. 🙂
- Web |
- More Posts(101)
Related posts:
- Applicant Arguments on the USPTO non-final rejection of the “NGAL exclusion patent” application. (Page 1) ...
- What is NGAL, and what’s its use? (Youtube Video) ...
- Spectrum Chart If you look at my chart on SPPI you can...
- BioPorto vs Phadia … BioPorto won 2-0 Today the judges of Sø & Handelsretten gave their verdict...
- The Appeal. ...
Ongoing debate
- Lesliejek on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Patrickciz on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Jameskipse on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- Rickiehiela on Chat transcript regarding the NGAL distr. Agreement with the Wiener Group. (In danish)
- James Rolitson on Good Discussion on Bronte Capital’s long thesis on Herbalife